You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ESPR Sale Disclosure
Halladay Benjamin · SEC Form 4 · Filed Jun 18, 2026
Sale
Calculated transaction value
$33.99K
Halladay Benjamin Chief Financial Officer
ESPR
Transaction date
Jun 17, 2026
Public filing date
Jun 18, 2026
Filing lag
Filed 1 day later
ESPR daily price context
Close on/before transaction
$3.17
Jun 17, 2026
First close after public filing
$3.16
Jun 22, 2026
Return after filing · so far
+0.63%
Through Jul 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 10,773 shares @ $3.15
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-044264
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$33.99K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Esperion Therapeutics, Inc. ESPR Current | Sale | Jun 17, 2026 | $33.99K |